We cannot analyze endemic mycoses as we did just a few years ago. These fungal diseases have acquired much larger importance, and many have disseminated to novel areas of the globe. Immunosuppression has put additional patients at risk. Moreover, diagnosis has now been improved via antigen detection and/or molecular techniques, and innovations in treatment have also occurred. This reprint deals specifically with recent advances in the epidemiology, diagnosis, and treatment of endemic mycoses.